<?xml version="1.0" encoding="UTF-8"?>
<edgarSubmission xmlns="http://www.sec.gov/edgar/rega/oneafiler" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>DOS</submissionType>
    <filerInfo>
      <liveTestFlag>LIVE</liveTestFlag>
      <filer>
        <issuerCredentials>
          <cik>0001424812</cik>
          <ccc>XXXXXXXX</ccc>
        </issuerCredentials>
      </filer>
      <flags>
        <returnCopyFlag>false</returnCopyFlag>
        <overrideInternetFlag>false</overrideInternetFlag>
      </flags>
    </filerInfo>
  </headerData>
  <formData>
    <employeesInfo>
      <issuerName>Amarantus Bioscience Holdings, Inc.</issuerName>
      <jurisdictionOrganization>NV</jurisdictionOrganization>
      <yearIncorporation>2008</yearIncorporation>
      <cik>0001424812</cik>
      <sicCode>2834</sicCode>
      <irsNum>26-0690857</irsNum>
      <fullTimeEmployees>4</fullTimeEmployees>
      <partTimeEmployees>1</partTimeEmployees>
    </employeesInfo>
    <issuerInfo>
      <street1>110 Wall St.</street1>
      <city>New York</city>
      <stateOrCountry>NY</stateOrCountry>
      <zipCode>10005</zipCode>
      <phoneNumber>9176865317</phoneNumber>
      <connectionName>William Eilers, Eilers Law Gro</connectionName>
      <industryGroup>Other</industryGroup>
      <cashEquivalents>94.00</cashEquivalents>
      <investmentSecurities>9341657.00</investmentSecurities>
      <accountsReceivable>826793.00</accountsReceivable>
      <propertyPlantEquipment>0.00</propertyPlantEquipment>
      <totalAssets>10173500.00</totalAssets>
      <accountsPayable>12418269.00</accountsPayable>
      <longTermDebt>18658497.00</longTermDebt>
      <totalLiabilities>31076766.00</totalLiabilities>
      <totalStockholderEquity>-20903266.00</totalStockholderEquity>
      <totalLiabilitiesAndEquity>10173500.00</totalLiabilitiesAndEquity>
      <totalRevenues>0.00</totalRevenues>
      <costAndExpensesApplToRevenues>-2518380.00</costAndExpensesApplToRevenues>
      <depreciationAndAmortization>940561.00</depreciationAndAmortization>
      <netIncome>-3458941.00</netIncome>
      <earningsPerShareBasic>0.00</earningsPerShareBasic>
      <earningsPerShareDiluted>0.00</earningsPerShareDiluted>
    </issuerInfo>
    <commonEquity>
      <commonEquityClassName>Common</commonEquityClassName>
      <outstandingCommonEquity>233158484</outstandingCommonEquity>
      <commonCusipEquity>02300U205</commonCusipEquity>
      <publiclyTradedCommonEquity>OTCPinksheets</publiclyTradedCommonEquity>
    </commonEquity>
    <preferredEquity>
      <preferredEquityClassName>Series A</preferredEquityClassName>
      <outstandingPreferredEquity>0</outstandingPreferredEquity>
      <preferredCusipEquity>000000000</preferredCusipEquity>
      <publiclyTradedPreferredEquity>NONE</publiclyTradedPreferredEquity>
    </preferredEquity>
    <preferredEquity>
      <preferredEquityClassName>Series B</preferredEquityClassName>
      <outstandingPreferredEquity>0</outstandingPreferredEquity>
      <preferredCusipEquity>000000000</preferredCusipEquity>
      <publiclyTradedPreferredEquity>NONE</publiclyTradedPreferredEquity>
    </preferredEquity>
    <preferredEquity>
      <preferredEquityClassName>Series C</preferredEquityClassName>
      <outstandingPreferredEquity>0</outstandingPreferredEquity>
      <preferredCusipEquity>000000000</preferredCusipEquity>
      <publiclyTradedPreferredEquity>NONE</publiclyTradedPreferredEquity>
    </preferredEquity>
    <preferredEquity>
      <preferredEquityClassName>Series D</preferredEquityClassName>
      <outstandingPreferredEquity>0</outstandingPreferredEquity>
      <preferredCusipEquity>000000000</preferredCusipEquity>
      <publiclyTradedPreferredEquity>NONE</publiclyTradedPreferredEquity>
    </preferredEquity>
    <preferredEquity>
      <preferredEquityClassName>Series E</preferredEquityClassName>
      <outstandingPreferredEquity>8699161</outstandingPreferredEquity>
      <preferredCusipEquity>000000000</preferredCusipEquity>
      <publiclyTradedPreferredEquity>NONE</publiclyTradedPreferredEquity>
    </preferredEquity>
    <preferredEquity>
      <preferredEquityClassName>Series F</preferredEquityClassName>
      <outstandingPreferredEquity>0</outstandingPreferredEquity>
      <preferredCusipEquity>000000000</preferredCusipEquity>
      <publiclyTradedPreferredEquity>NONE</publiclyTradedPreferredEquity>
    </preferredEquity>
    <preferredEquity>
      <preferredEquityClassName>Series G</preferredEquityClassName>
      <outstandingPreferredEquity>0</outstandingPreferredEquity>
      <preferredCusipEquity>000000000</preferredCusipEquity>
      <publiclyTradedPreferredEquity>NONE</publiclyTradedPreferredEquity>
    </preferredEquity>
    <preferredEquity>
      <preferredEquityClassName>Series H</preferredEquityClassName>
      <outstandingPreferredEquity>4202446</outstandingPreferredEquity>
      <preferredCusipEquity>000000000</preferredCusipEquity>
      <publiclyTradedPreferredEquity>NONE</publiclyTradedPreferredEquity>
    </preferredEquity>
    <debtSecurities>
      <debtSecuritiesClassName>NONE</debtSecuritiesClassName>
      <outstandingDebtSecurities>0</outstandingDebtSecurities>
      <cusipDebtSecurities>000000000</cusipDebtSecurities>
      <publiclyTradedDebtSecurities>NONE</publiclyTradedDebtSecurities>
    </debtSecurities>
    <issuerEligibility>
      <certifyIfTrue>true</certifyIfTrue>
    </issuerEligibility>
    <applicationRule262>
      <certifyIfNotDisqualified>true</certifyIfNotDisqualified>
      <certifyIfBadActor>false</certifyIfBadActor>
    </applicationRule262>
    <summaryInfo>
      <indicateTier1Tier2Offering>Tier1</indicateTier1Tier2Offering>
      <financialStatementAuditStatus>Unaudited</financialStatementAuditStatus>
      <securitiesOfferedTypes>Equity (common or preferred stock)</securitiesOfferedTypes>
      <offerDelayedContinuousFlag>Y</offerDelayedContinuousFlag>
      <offeringYearFlag>N</offeringYearFlag>
      <offeringAfterQualifFlag>Y</offeringAfterQualifFlag>
      <offeringBestEffortsFlag>Y</offeringBestEffortsFlag>
      <solicitationProposedOfferingFlag>N</solicitationProposedOfferingFlag>
      <resaleSecuritiesAffiliatesFlag>N</resaleSecuritiesAffiliatesFlag>
      <securitiesOffered>40000000</securitiesOffered>
      <pricePerSecurity>0.5000</pricePerSecurity>
      <issuerAggregateOffering>20000000.00</issuerAggregateOffering>
      <securityHolderAggegate>0.00</securityHolderAggegate>
      <qualificationOfferingAggregate>0.00</qualificationOfferingAggregate>
      <concurrentOfferingAggregate>0.00</concurrentOfferingAggregate>
      <totalAggregateOffering>20000000.00</totalAggregateOffering>
      <legalServiceProviderName>Eilers Law Group, P.A.</legalServiceProviderName>
      <legalFees>15000.00</legalFees>
      <promotersServiceProviderName>None</promotersServiceProviderName>
      <promotersFees>15000.00</promotersFees>
      <blueSkyServiceProviderName>Self Filed</blueSkyServiceProviderName>
      <blueSkyFees>2000.00</blueSkyFees>
      <estimatedNetAmount>1000000.00</estimatedNetAmount>
    </summaryInfo>
    <juridictionSecuritiesOffered>
      <jurisdictionsOfSecOfferedNone>true</jurisdictionsOfSecOfferedNone>
      <jurisdictionsOfSecOfferedSame>false</jurisdictionsOfSecOfferedSame>
      <issueJuridicationSecuritiesOffering>NY</issueJuridicationSecuritiesOffering>
    </juridictionSecuritiesOffered>
    <unregisteredSecurities>
      <ifUnregsiteredNone>false</ifUnregsiteredNone>
    </unregisteredSecurities>
    <securitiesIssued>
      <securitiesIssuerName>Amarantus Bioscience Holding, Inc.</securitiesIssuerName>
      <securitiesIssuerTitle>Series E and Series H Preferred</securitiesIssuerTitle>
      <securitiesIssuedTotalAmount>12902</securitiesIssuedTotalAmount>
      <securitiesPrincipalHolderAmount>0</securitiesPrincipalHolderAmount>
      <securitiesIssuedAggregateAmount>Settlement of Existing Debt</securitiesIssuedAggregateAmount>
    </securitiesIssued>
    <unregisteredSecuritiesAct>
      <securitiesActExcemption>Section 4(a)(2) and Section 3(a)(9) of the Securities Act</securitiesActExcemption>
    </unregisteredSecuritiesAct>
  </formData>
</edgarSubmission>